The objective of the Transgenic Mouse/ES Cell Shared Resource to investigators production is assist in the and use of transgenic and gene knockout mice. Through an interdisciplinary approach, the Resource has been able to provide a broader array of services than are available elsewhere to a large base of investigators. The Shared Resource focuses on quality control, the increased potential for collegial interactions, and immediate access to individuals with deep knowledge of transgenic mice. Experienced personnel develop new procedures and applications, such as those that facilitate the use of site-specific recombinases to perform tissue-specific gene knockouts. As the technology for genome manipulation continues to expand, the Transgenic Mice/ES Cell Shared Resource is likely to grow with it. Specifically, the Shared Resource offers pronuclear DNA microinjection; ES cell microinjection into blastocysts; assisted reproduction; gene targeting; and conditional knockouts utilizing the Cre or FIp(e) site-specific recombinase system; embryo cryopreservation and long-term storage; and sperm cryopreservation and storage. Dr. Cathleen Pettepher is the Director of the Transgenic Mouse/ES Cell Shared Resource and offers consultation to investigators, reviews and approves requests for gene targeting experiments and DNA or ES cell microinjections, and tracks the efficiency and quality of the services offered. She has a highly-trained staff that helps her serve VICC researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA068485-09
Application #
6990171
Study Section
Subcommittee G - Education (NCI)
Project Start
2004-09-28
Project End
2009-08-31
Budget Start
2004-09-28
Budget End
2005-08-31
Support Year
9
Fiscal Year
2004
Total Cost
$102,068
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Cardin, Dana B; Goff, Laura W; Chan, Emily et al. (2018) Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial. Invest New Drugs 36:442-450
Yang, Jinming; Kumar, Amrendra; Vilgelm, Anna E et al. (2018) Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Cancer Immunol Res 6:1186-1198
Alvarado, Gabriela; Ettayebi, Khalil; Atmar, Robert L et al. (2018) Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses. Gastroenterology 155:1898-1907
Sierra, Johanna C; Asim, Mohammad; Verriere, Thomas G et al. (2018) Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis. Gut 67:1247-1260
Guo, Xingyi; Lin, Weiqiang; Bao, Jiandong et al. (2018) A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies. Am J Hum Genet 102:890-903
Garcia, A Denise R; Han, Young-Goo; Triplett, Jason W et al. (2018) The Elegance of Sonic Hedgehog: Emerging Novel Functions for a Classic Morphogen. J Neurosci 38:9338-9345
Lu, Sichang; McGough, Madison A P; Shiels, Stefanie M et al. (2018) Settable polymer/ceramic composite bone grafts stabilize weight-bearing tibial plateau slot defects and integrate with host bone in an ovine model. Biomaterials 179:29-45
Santos Guasch, Gabriela L; Beeler, J Scott; Marshall, Clayton B et al. (2018) p73 Is Required for Ovarian Follicle Development and Regulates a Gene Network Involved in Cell-to-Cell Adhesion. iScience 8:236-249
West, Kathryn L; Kelm, Nathaniel D; Carson, Robert P et al. (2018) Myelin volume fraction imaging with MRI. Neuroimage 182:511-521
May-Zhang, Aaron A; Deal, Karen K; Southard-Smith, E Michelle (2018) Optimization of Laser-Capture Microdissection for the Isolation of Enteric Ganglia from Fresh-Frozen Human Tissue. J Vis Exp :

Showing the most recent 10 out of 2462 publications